$2.09
Today
as of Sep 4, 16:53 ET
Last 30 days
Recent Press Releases & News
Palisade Bio to Participate in Upcoming Investor Conferences
Palisade Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of PALI-2108 Into Phase 2 Development
Palisade Bio Draws Bullish Call, Lead IBD Drug Advances Toward Phase 2
Overview
52-week range
$0.53
$2.86
67% of range
Avg surprise (last 3)
-0.6%
Avg reaction (last 2)
+0.8%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.05 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $-0.05 | $-0.04 | -25.0% | +89.4% | -1.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.38 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-0.58 | $-0.48 | -20.8% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.47 | $-0.84 | +44.0% | — | +2.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-2.32 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-3.32 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-4.59 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-7.38 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-7.93 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-8.13 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $500,000 | $0 | — | $0 | $0 | $0 | — | $0 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-12M | $-11M | — | $-3M | $-3M | $-2M | — | $-4M |
| Net income | $-11M | $-10M | — | $-3M | $-3M | $-2M | — | $-3M |
| EPS (diluted) | $-0.05 | $-0.05 | — | $-0.38 | $-0.58 | $-0.47 | — | $-2.32 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $125M | $133M | $133M | $5M | $5M | $7M | $10M | $8M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $127M | $133M | $134M | $7M | $6M | $8M | $10M | $9M |
| Total assets | $127M | $133M | $134M | $7M | $7M | $8M | $11M | $9M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $6M | $6M | $5M | $4M | $4M | $3M | $3M | $3M |
| Total equity | $122M | $127M | $129M | $3M | $3M | $5M | $7M | $7M |
Implied volatility — last 90 days
No IV snapshots yet for PALI.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.